FESOTERODINE FUMARATE
- Product NDC
- 65862-767
- 11-digit product format
- 658620767
- Labeler code
- 65862
- Product ID
- 65862-767_33d91059-f2d5-482f-a47f-b1dccb7c5b22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FESOTERODINE FUMARATE
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA205007
- Marketing category
- ANDA
- Marketing start
- 2022-06-17
- Substance
- FESOTERODINE FUMARATE
- Active strength
- 8 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A205007-001 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | |
| A205007-002 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A205007-001 | AB |
| A205007-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A205007-001 | FESOTERODINE FUMARATE | 4MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A205007-002 | FESOTERODINE FUMARATE | 8MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2017-02-17 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A205007-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A205007-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A205007-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A205007-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205007-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A205007-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A205007-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A205007-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205007-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A205007-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205007-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A205007-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205007-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A205007-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205007-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A205007-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205007-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A205007-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205007-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A205007-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A205007-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A205007-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205007-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A205007-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205007-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A205007-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205007-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A205007-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A205007-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A205007-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205007-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A205007-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A205007-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A205007-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A205007-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A205007-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A205007-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A205007-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A205007-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A205007-002 | AB | 1 | bb7c543d1eb4… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FESOTERODINE FUMARATE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FESOTERODINE FUMARATE | 8 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| EOS72165S7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 929b9598-46e7-5b66-7a86-5544524fb173 | Product name | 6 | 20240208 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65862-767-30 | FESOTERODINE FUMARATE | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65862-767-30 | EA - Each | 65862-767 | aa455e7d-2026-4f16-b40b-13114fa2517b | 1 | 2022-07-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FESOTERODINE FUMARATE | FESOTERODINE FUMARATE | Aurobindo Pharma Limited | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 2024-12-02 | Warnings, Adverse reactions | 205007 ANDA205007 65862-767 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 810071 | fesoterodine fumarate 4 MG 24HR Extended Release Oral Tablet | PSN | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
| 810077 | fesoterodine fumarate 8 MG 24HR Extended Release Oral Tablet | PSN | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
| 810071 | 24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet | SCD | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
| 810077 | 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet | SCD | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
| 810071 | fesoterodine fumarate 4 MG 24 HR Extended Release Oral Tablet | SY | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
| 810077 | fesoterodine fumarate 8 MG 24 HR Extended Release Oral Tablet | SY | dc8f6158-3c2b-4ec0-a951-e04468b83bb1 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 65862-767-30 | 65862076730 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-767-30) | 2022-06-17 | 0000-00-00 | No | No | Current |